Recent Finacing
Recent Raise
Escalier Biosciences develops small-molecule RORγt inhibitors to reduce IL-17 for psoriasis and other autoimmune disorders, advancing oral and topical candidates through late-stage preclinical development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Escalier Biosciences.
